Home News APCR Response to Speaker Pelosi's Proposed Medicare Changes
APCR Response to Speaker Pelosi's Proposed Medicare Changes
posted: September 19, 2019
House Speaker Nancy Pelosi released a plan today on changes to the way the U.S. values and reimburses prescription drugs, including in the Medicare program, which will have significant impacts on clinical research in the future. The plan would enable direct price negotiation on up to 250 drugs, implement new liabilities in the Medicare program, new price controls, and the hammer of a 65-95% new tax. These policies will impact investment in clinical research and innovation may suffer as a result. The Academy of Physicians in Clinical Research (APCR) released the following statement regarding the proposed changes.
Read the Full Letter